IDXX · ISSUER CIK 874716
IDEXX LABORATORIES INC /DE
Between Aug 1, 2026 and Oct 29, 2026, 3 IDEXX LABORATORIES INC /DE insiders reported $0.00 of open-market purchases and $1.2M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.2MInsider selling
−$1.2MNet open-market
Sep 9, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 202617:00 | Sep 4, 2026 | IDXX | Director | S · SellLate 5d | $532.08 | −2,203 | 9,568 | -19% | −$1.2M | ||
| Sep 9, 202617:00 | Sep 4, 2026 | IDXX | Director | M · ExerciseLate 5d | $114.17 | +2,203 | 11,771 | +23% | $252K | ||
| Aug 24, 202617:00 | Aug 20, 2026 | IDXX | EVP, CFO and Treasurer | M · Exercise | $178.26 | +265 | 4,507 | +6% | $47K | ||
| Aug 24, 202617:00 | Aug 20, 2026 | IDXX | EVP, CFO and Treasurer | F · Tax | — | −86 | 4,421 | -2% | — | ||
| Aug 3, 202617:00 | Jul 30, 2026 | IDXX | Director | A · Grant | $558.80 | +49 | 325 | +18% | $27K |